Autopsy report · NCT02508935
Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
Cause of deathFunding or business
“Business decision”
Life of this trial
- Registered 5 months before it started.
- Ran for about 1 year 5 months before it stopped.
- 23 participants enrolled.
- Results were posted on the registry 2 years 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Mallinckrodt
- Sponsor type
- Industry
- Conditions
- Acute Pain
- Interventions
- XARTEMIS XR
- Participants
- 23
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.